Provincial report card

Quebec

4 of 8 categories assessed · Evidence assessed to August 2025

Not gradedInsufficient data

Only 4 of 8 categories could be assessed from the research inventories, below the five-category minimum for a grade. The mean of the assessed categories (2.3) is shown for transparency only. Missing evidence is never scored as zero.

How Quebec scored, category by category

1 · Strategy & pancreatic focus

2 / 4

Quebec's Plan d'action en cancérologie 2024–2026 sets eight strategic axes with orientations to 2030 and published targets for colorectal, breast, and cervical screening; no pancreatic-specific provisions are documented.

2 · Biomarker & genetic testing

2 / 4

A provincial process (INESSS/RQDM) exists to add genomic tests to the Répertoire and the RQDM supports NGS repatriation, recorded as "Ongoing"; no comprehensive funded province-wide program is documented.

3 · Drug coverage & patient costs

Not assessable

Not obtainable: Quebec drug coverage and patient costs are not covered in the corpus beyond its separate drug-review structure — Quebec sits outside the pCODR recommendation structure and its separate system is noted as limiting pan-Canadian coherence.

4 · Clinical trials access

3 / 4

Montreal is recorded at 34% in the corpus's trial-activity concentration figures, and Quebec is listed among the provinces with clinical trial sites. Not obtainable: no Quebec-specific enrolment rate is documented.

5 · Timely care — waits & surgical capacity

Not assessable

Not obtainable: Quebec wait times and pancreatic surgical capacity are not covered in the corpus.

6 · Travel & transport support

Not assessable

Not obtainable: Quebec travel and transport supports are not covered in the corpus.

7 · Workforce, navigation & support

Not assessable

Not obtainable: Quebec workforce and navigation are not covered in the corpus.

8 · Research funding & representation

2 / 4

McGill accounts for 21 of the 270 records in the national CIHR register compiled for this research — one of the four concentration institutions. Not obtainable: institution-level counts within the 88 pancreatic-flagged records are not published in the findings beyond the largest grants, so this score rests on register presence.

Strongest areas

Clinical trials access3 of 4

Grades rest on structured research inventories reviewed and verified by The Heather Cutler Foundation. They assess documented systems, not individual care. See all thirteen jurisdictions · Read the full report